Lake Street Maintains Buy on LeMaitre Vascular, Raises Price Target to $75
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Brooks O'Neil maintains a 'Buy' rating on LeMaitre Vascular (NASDAQ:LMAT) and raises the price target from $65 to $75.
August 04, 2023 | 11:45 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LeMaitre Vascular's price target has been raised from $65 to $75 by Lake Street, maintaining a 'Buy' rating.
The raised price target indicates the analyst's increased confidence in the company's future performance. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100